Cassava Sciences (NASDAQ:SAVA) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Cassava Sciences Stock (NASDAQ: SAVA) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	911.00 / 3.40M
Day Range	- - -
52 Wk Range	8.79 - 42.20
Market Cap	$1.50B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	60
Short Interest	35.18%
Days to Cover	10.38

Recent News

What's Going On With Cassava Sciences Today?

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading higher Monday. Here's what you need to know.

Vaishali Prayag

Cassava Sciences Shares Are Trading Higher Today: What You Need To Know

Cassava Sciences, Inc. (NASDAQ: SAVA) saw its stock price soar by 15.5% to $27.13, an increase of $3.64, amid rising short interest and an anticipated conference call to discuss recent developments.

Vaishali Prayag

8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%

Macro environment favors large-caps, but July saw impressive gains for small-caps, with Serve Robotics leading at 803% and Q32 Bio at 101%.

Hayden Buckfire

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Cassava Sciences Inc

Sector

Health Care

Industry

Pharmaceuticals

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific ap...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Cassava Sciences (SAVA) stock?

You can purchase shares of Cassava Sciences (NASDAQ:SAVA) through any online brokerage.

View our list of the best stock brokerages

Who are Cassava Sciences (SAVA) competitors?

Other companies in Cassava Sciences’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Neumora Therapeutics (NASDAQ:NMRA) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for Cassava Sciences (SAVA) stock?

Cassava Sciences has a consensus price target of $75.50.

What is the current price for Cassava Sciences (SAVA)?

The stock price for Cassava Sciences (NASDAQ: SAVA) is $31.24 last updated September 19, 2024 at 7:30 AM EDT.

Does Cassava Sciences (SAVA) pay a dividend?

A quarterly cash dividend of 0.75 per share of Class A Common Stock. The quarterly cash dividend was payable on December 24, 2012 to stockholders of record on December 13, 2012.

When is Cassava Sciences (NASDAQ:SAVA) reporting earnings?

Cassava Sciences’s Q3 earnings are confirmed for Tuesday, November 5, 2024.

Is Cassava Sciences (SAVA) going to split?

There is no upcoming split for Cassava Sciences.

What sector and industry does Cassava Sciences (SAVA) operate in?

Cassava Sciences is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now